2019
MR Angiography Screening and Surveillance for Intracranial Aneurysms in Autosomal Dominant Polycystic Kidney Disease: A Cost-effectiveness Analysis
Malhotra A, Wu X, Matouk CC, Forman HP, Gandhi D, Sanelli P. MR Angiography Screening and Surveillance for Intracranial Aneurysms in Autosomal Dominant Polycystic Kidney Disease: A Cost-effectiveness Analysis. Radiology 2019, 291: 400-408. PMID: 30777807, DOI: 10.1148/radiol.2019181399.Peer-Reviewed Original Research
2018
Management of Tiny Unruptured Intracranial Aneurysms: A Comparative Effectiveness Analysis
Malhotra A, Wu X, Forman HP, Matouk CC, Gandhi D, Sanelli P. Management of Tiny Unruptured Intracranial Aneurysms: A Comparative Effectiveness Analysis. JAMA Neurology 2018, 75: 27-34. PMID: 29159405, PMCID: PMC5833486, DOI: 10.1001/jamaneurol.2017.3232.Peer-Reviewed Original ResearchConceptsUnruptured intracranial aneurysmsComparative effectiveness analysisPreventive treatmentAdult patientsAnnual riskIntracranial aneurysmsHealth benefitsFollow-up imagingCurrent clinical practiceBetter health outcomesRisk of ruptureImaging surveillanceTiny aneurysmsMean ageSubarachnoid hemorrhageRoutine treatmentIncidental detectionEffectiveness analysisClinical studiesMAIN OUTCOMEHigh riskGeneral populationPatientsPubMed searchClinical practice
2016
The Use of High-Risk Criteria in Screening Patients for Blunt Cerebrovascular Injury A Survey
Wu X, Malhotra A, Forman HP, Nunez D, Sanelli P. The Use of High-Risk Criteria in Screening Patients for Blunt Cerebrovascular Injury A Survey. Academic Radiology 2016, 24: 456-461. PMID: 27979639, DOI: 10.1016/j.acra.2016.11.010.Peer-Reviewed Original ResearchMeSH KeywordsAttitude of Health PersonnelCerebral AngiographyCerebrovascular TraumaComputed Tomography AngiographyDatabases, FactualDelayed DiagnosisEmergency Service, HospitalHumansMagnetic Resonance AngiographyMass ScreeningRadiologistsRisk AssessmentRisk FactorsSurveys and QuestionnairesUnited StatesWounds, NonpenetratingConceptsBlunt cerebrovascular injuryRisk factorsEmergency departmentCT angiographyDenver criteriaMR angiographyC1-C3 fracturesUtilization of imagingCerebrovascular injuryBlunt injuryBlunt traumaScreening ratesAngiographic studiesLarge academic institutionVascular injuryScreening patientsPatientsPreferred modalityRoutine useInjurySubsequent strokeAngiographyScreening criteriaPhysiciansRadiologistsCost-Effectiveness of Tomosynthesis in Annual Screening Mammography.
Kalra VB, Wu X, Haas BM, Forman HP, Philpotts LE. Cost-Effectiveness of Tomosynthesis in Annual Screening Mammography. American Journal Of Roentgenology 2016, 207: 1152-1155. PMID: 27547861, DOI: 10.2214/ajr.15.14487.Peer-Reviewed Original Research
2007
CT screening for lung cancer: implications on social responsibility.
Lee CI, Forman HP. CT screening for lung cancer: implications on social responsibility. American Journal Of Roentgenology 2007, 188: 297-8. PMID: 17242233, DOI: 10.2214/ajr.07.5212.Peer-Reviewed Original Research
1994
Chest Radiography in Patients With Early Stage Prostatic Carcinoma Effect on Treatment Planning and Cost Analysis
Forman H, Fox L, Glazer H, McClennan B, Anderson D, Sagel S. Chest Radiography in Patients With Early Stage Prostatic Carcinoma Effect on Treatment Planning and Cost Analysis. CHEST Journal 1994, 106: 1036-1041. PMID: 7523036, DOI: 10.1378/chest.106.4.1036.Peer-Reviewed Original ResearchConceptsProstatic carcinomaChest radiographyChest radiographsRoutine preoperative chest radiographsChest radiography findingsRoutine chest radiographyRetropubic radical prostatectomyHospital-based outpatientPreoperative chest radiographProstate-specific antigenCost-effectiveness modelIntrathoracic metastasesRadiography findingsProspective studyPatient populationRadical prostatectomyClinical impactProstate carcinomaPatientsSpecific antigenPositive findingsFurther evaluationCarcinomaTreatment planningRadiographsCT screening for comorbid disease in patients with prostatic carcinoma: is it cost-effective?
Forman H, Heiken J, Brink J, Glazer H, Fox L, McClennan B. CT screening for comorbid disease in patients with prostatic carcinoma: is it cost-effective? American Journal Of Roentgenology 1994, 162: 1125-8; discussion 1129-30. PMID: 8165996, DOI: 10.2214/ajr.162.5.8165996.Peer-Reviewed Original ResearchConceptsComorbid diseasesProstatic carcinomaCT findingsFalse-positive CT findingsTime of diagnosisPopulation of patientsLack of efficacyScreening CT scanConsecutive patientsPreoperative evaluationProstatic surgeryMedical recordsClinical impactCT scanRadiation therapyPatientsCarcinomaFurther evaluationDiseaseCTMedicare reimbursementSurgeryTreatmentFindingsTherapy